The Iliac/SFA/Popliteal Center

Filter Your Results




Data Presented on Biotronik's Passeo-18 Lux DCB and Pulsar-18 BMS

January 25, 2017 -- Biotronik announced that interim data on the efficacy of the company's dedicated lower limb intervention portfolio were presented during a scientific s…

Medtronic In.Pact Admiral DCB Evaluated in Study Cohorts in Asia and Belgium

January 25, 2017 -- Medtronic announced that new data for its In.Pact Admiral drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) were present…

CE Mark Approval for Medtronic's HawkOne 6-F Directional Atherectomy System

January 24, 2017 -- Medtronic announced that is has received European CE Mark approval for its HawkOne directional atherectomy system in a lower-profile size to patients …

ILLUMENATE Global 12-Month Data Presented for Spectranetics' Stellarex DCB

January 24, 2017 -- The Spectranetics Corporation announced that the final 12-month results from the ILLUMENATE Global Study of the Stellarex drug-coated balloon (DC…

PQ Bypass Announces DETOUR I Study Results

January 24, 2017 -- PQ Bypass, which is developing a fully percutaneous bypass treatment for patients with long, complex superficial femoral artery (SFA) occlusions, announced…

Building a Comprehensive CLI Program

J.A. Mustapha, MD; Larry J. Diaz-Sandoval, MD; Mike Sumners, DO; and Fadi Saab, MD

January 2017—The multitasking, multidisciplinary team approach to addressing this multilevel disease.

Cilostazol After DES Studied in Femoropopliteal Lesions

January 11, 2017 -- A study of cilostazol treatment after drug-eluting stent (DES) procedures for femoropopliteal lesions showed a reduction of stent restenosis in patients wi…

Optical Frequency Domain Imaging Compares Vascular Response of BMS Versus DES in SFA

January 11, 2017 -- An investigation of differences in vascular response between self-expanding nitinol bare-metal stents (BMSs) and nitinol paclitaxel-eluting stents (PESs) i…



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.